Over a four-year period, researchers from Belgium, Spain, Italy, Germany, the UK, the Netherlands and Norway will combine their expertise in the fields of numerics, mathematical modeling and pharmacology. Their aim is to combine data from online sources, such as electronic health records, with data from modeling and simulation, to provide regulators with up-to-date information to enable them to make informed decisions. To this end, the project will analyze five cases of specific drug use for pediatric and rare conditions, with the aim of assessing the associated benefits and risks. Each of these cases should lead to the approval of at least one modeling and simulation tool by the European Medicines Agency (EMA).
The deliverables expected for a project of this scale are numerous. In particular, they include the creation of a repository, the establishment of quality standards, the implementation of training courses for healthcare players, and the development of an artificial intelligence platform dedicated to automating data collection, formatting, analysis and evaluation.
ERAMET is a project of the European Union's HORIZON Europe programming.
Grantor: 101137141 - ERAMET